Target intelligence / Profile preview

PPT2-EGFL8 readthrough (PPT2-EGFL8)

Target
PPT2-EGFL8
Molecular classification
Other: non-coding RNA (readthrough, NMD candidate; transcript, not protein), Related to lysosomal thioesterase family if inferring from PPT2
01

Overview

The PPT2-EGFL8 locus represents a read-through transcript between the palmitoyl-protein thioesterase 2 (PPT2) and EGF-like domain multiple 8 (EGFL8) genes, found within the major histocompatibility complex region on chromosome 6. This transcript is classified as a nonsense-mediated decay (NMD) candidate and is generally not thought to produce a functional protein product[3][7]. The fusion gene has been implicated in rare genetic disorders with developmental abnormalities and intellectual disability, possibly through the unique structure combining the phosphatase domain of PPT2 with an EGFL8 domain[1]. However, its precise biological function and clinical significance remain largely hypothetical, with most functional disease data attributed to PPT2 itself, a lysosomal enzyme involved in palmitoyl-CoA hydrolysis and lipid metabolism[2][5][8]. PPT2 deficiency leads to neurodegenerative disorders in model organisms, but the PPT2-EGFL8 fusion transcript has limited direct clinical or therapeutic characterization.

Other names
PPT-2PPT2Lysosomal thioesterase PPT2S-thioesterase G14C6orf8EGFL8 readthroughPPT2-EGFL8
02

Mechanism of action

None established for this transcript. For PPT2 enzyme: palmitoyl-CoA hydrolysis by lysosomal thioesterase mechanism

03

Biological functions

For the fusion: Unknown/uncertain (possible experimental roles in RNA decay, rare disorders)For PPT2 (not the fusion): Lipid metabolismFor PPT2 (not the fusion): Hydrolysis of palmitoyl-CoA thioestersFor PPT2 (not the fusion): Lysosomal catabolism
04

Disease associations

For the fusion: Rare genetic disorders (possible links via case reports)For the fusion: Developmental abnormalities, intellectual disability (speculative association)For PPT2 (not fusion): Infantile neuronal ceroid lipofuscinosis (neurodegeneration)For PPT2 (not fusion): Type 2 diabetes mellitusFor PPT2 (not fusion): Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndromeFor PPT2 (not fusion): AceruloplasminemiaFor PPT2 (not fusion): Hypouricemia, renal, 2For PPT2 (not fusion): Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2For PPT2 (not fusion): Ataxia-pancytopenia syndrome
05

Safety considerations

No documented therapeutic applications, nor known safety concerns for targeting this transcript.
06

Biomarkers

None specific for PPT2-EGFL8; potential for disease monitoring of PPT2 activity in neurodegenerative contexts but not established for fusion.

Beyond the preview

Go deeper on PPT2-EGFL8 readthrough (PPT2-EGFL8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PPT2-EGFL8 readthrough (PPT2-EGFL8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call